Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Colorectal Neoplasms

  Free Subscription


09.09.2019

2 Ann Surg
1 Ann Surg Oncol
3 BMC Cancer
2 Br J Cancer
5 Br J Surg
1 Cancer
1 Dis Colon Rectum
2 Gastroenterology
1 Gut
1 Int J Cancer
3 Int J Colorectal Dis
1 Int J Oncol
2 J Surg Oncol
3 Oncogene
2 PLoS One
1 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg

  1. RAOOF M, Haye S, Ituarte PHG, Fong Y, et al
    Liver Resection Improves Survival in Colorectal Cancer Patients: Causal-Effects From Population-Level Instrumental Variable Analysis.
    Ann Surg. 2019 Aug 29. doi: 10.1097/SLA.0000000000003485.
    PubMed     Text format     Abstract available

  2. MISE Y, Hasegawa K, Satou S, Shindoh J, et al
    How Has Virtual Hepatectomy Changed the Practice of Liver Surgery?: Experience of 1194 Virtual Hepatectomy Before Liver Resection and Living Donor Liver Transplantation.
    Ann Surg. 2017 Mar 10. doi: 10.1097/SLA.0000000000002213.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  3. IWAMOTO K, Takahashi H, Fujii M, Haraguchi N, et al
    Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer: Propensity Score-Matched Analysis.
    Ann Surg Oncol. 2019 Sep 6. pii: 10.1245/s10434-019-07794.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. CONRADI LC, Spitzner M, Metzger AL, Kisly M, et al
    Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer.
    BMC Cancer. 2019;19:880.
    PubMed     Text format     Abstract available

  5. AL-HUSSEINI MJ, Saad AM, Mohamed HH, Alkhayat MA, et al
    Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria.
    BMC Cancer. 2019;19:863.
    PubMed     Text format     Abstract available

  6. HAGHI F, Goli E, Mirzaei B, Zeighami H, et al
    The association between fecal enterotoxigenic B. fragilis with colorectal cancer.
    BMC Cancer. 2019;19:879.
    PubMed     Text format     Abstract available


    Br J Cancer

  7. KUWAHARA T, Hazama S, Suzuki N, Yoshida S, et al
    Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
    Br J Cancer. 2019 Sep 6. pii: 10.1038/s41416-019-0559.
    PubMed     Text format     Abstract available

  8. LOUPAKIS F, Biason P, Prete AA, Cremolini C, et al
    CK7 and consensus molecular subtypes as major prognosticators in (V600E)BRAF mutated metastatic colorectal cancer.
    Br J Cancer. 2019 Sep 2. pii: 10.1038/s41416-019-0560.
    PubMed     Text format     Abstract available


    Br J Surg

  9. KELLER DS, Reali C, Spinelli A, Penna M, et al
    Patient-reported functional and quality-of-life outcomes after transanal total mesorectal excision.
    Br J Surg. 2019;106:364-366.
    PubMed     Text format     Abstract available

  10. AHL R, Matthiessen P, Fang X, Cao Y, et al
    Effect of beta-blocker therapy on early mortality after emergency colonic cancer surgery.
    Br J Surg. 2019;106:477-483.
    PubMed     Text format     Abstract available


  11. Snapshot quiz.
    Br J Surg. 2019;106:341.
    PubMed     Text format    

  12. VAN 'T SANT I, van Eden WJ, Engbersen MP, Kok NFM, et al
    Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery.
    Br J Surg. 2019;106:491-498.
    PubMed     Text format     Abstract available

  13. LAU YC, Jongerius K, Wakeman C, Heriot AG, et al
    Influence of the level of sacrectomy on survival in patients with locally advanced and recurrent rectal cancer.
    Br J Surg. 2019;106:484-490.
    PubMed     Text format     Abstract available


    Cancer

  14. MYERS RE
    Low rates of diagnostic colonoscopy in Federally Qualified Health Centers: A persistent problem that must be addressed to achieve the promise of colorectal cancer screening.
    Cancer. 2019 Sep 3. doi: 10.1002/cncr.32438.
    PubMed     Text format    


    Dis Colon Rectum

  15. LEIJSSEN LGJ, Dinaux AM, Taylor MS, Deshpande V, et al
    Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer.
    Dis Colon Rectum. 2019;62:1212-1221.
    PubMed     Text format     Abstract available


    Gastroenterology

  16. LIU G, Hu Y, Jiang Q
    Population Difference and Disease Status Affect the Association Between Genetic Variants and Gene Expression.
    Gastroenterology. 2019;157:894-896.
    PubMed     Text format    

  17. LU Y, Zheng W
    Reply.
    Gastroenterology. 2019;157:896-897.
    PubMed     Text format    


    Gut

  18. SIEGEL RL, Torre LA, Soerjomataram I, Hayes RB, et al
    Global patterns and trends in colorectal cancer incidence in young adults.
    Gut. 2019 Sep 5. pii: gutjnl-2019-319511. doi: 10.1136/gutjnl-2019-319511.
    PubMed     Text format     Abstract available


    Int J Cancer

  19. MOATI E, Blons H, Taly V, Garlan F, et al
    Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer.
    Int J Cancer. 2019 Aug 31. doi: 10.1002/ijc.32657.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  20. KELTY E, Ward SV, Cadby G, McCarthy NS, et al
    Familial and non-familial risk factors associated with colorectal cancer survival in young and middle-aged patients.
    Int J Colorectal Dis. 2019 Aug 30. pii: 10.1007/s00384-019-03380.
    PubMed     Text format     Abstract available

  21. ABDEL-RAHMAN O, Karachiwala H
    Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials.
    Int J Colorectal Dis. 2019 Sep 6. pii: 10.1007/s00384-019-03389.
    PubMed     Text format     Abstract available

  22. MAKIMOTO S, Takami T, Hatano K, Kataoka N, et al
    Additional surgery after endoscopic submucosal dissection for colorectal cancer: a review of 53 cases.
    Int J Colorectal Dis. 2019 Sep 2. pii: 10.1007/s00384-019-03370.
    PubMed     Text format     Abstract available


    Int J Oncol

  23. AN HJ, Park M, Kim J, Han YH, et al
    miR5191 functions as a tumor suppressor by targeting RPS6KB1 in colorectal cancer.
    Int J Oncol. 2019 Aug 30. doi: 10.3892/ijo.2019.4865.
    PubMed     Text format     Abstract available


    J Surg Oncol

  24. KYANG LS, Alzahrani NA, Valle SJ, Rahman MK, et al
    Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases.
    J Surg Oncol. 2019;120:794-802.
    PubMed     Text format     Abstract available

  25. STUART E, Banerjee S, de la Torre J, Wang Y, et al
    Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry.
    J Surg Oncol. 2019;120:715-721.
    PubMed     Text format     Abstract available


    Oncogene

  26. HE Y, Davies CM, Harrington BS, Hellmers L, et al
    CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of beta-catenin and E-cadherin.
    Oncogene. 2019 Aug 30. pii: 10.1038/s41388-019-0983.
    PubMed     Text format     Abstract available

  27. YANG S, Ren X, Liang Y, Yan Y, et al
    KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis.
    Oncogene. 2019 Sep 2. pii: 10.1038/s41388-019-0978.
    PubMed     Text format     Abstract available

  28. WEI TT, Lin YT, Tang SP, Luo CK, et al
    Metabolic targeting of HIF-1alpha potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer.
    Oncogene. 2019 Sep 2. pii: 10.1038/s41388-019-0999.
    PubMed     Text format     Abstract available


    PLoS One

  29. ALMUTAIRI M, Parine NR, Shaik JP, Aldhaian S, et al
    Association between polymorphisms in PRNCR1 and risk of colorectal cancer in the Saudi population.
    PLoS One. 2019;14:e0220931.
    PubMed     Text format     Abstract available

  30. NABER SK, Knudsen AB, Zauber AG, Rutter CM, et al
    Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries.
    PLoS One. 2019;14:e0220234.
    PubMed     Text format     Abstract available


    World J Surg

  31. LIM H, Kang S, Kim B, Ko S, et al
    Comparison Between Preoperative and Intraoperative Administration of Nefopam for Acute and Chronic Postoperative Pain in Colon Cancer Patients: A Prospective, Randomized, Double-Blind Study.
    World J Surg. 2019 Aug 27. pii: 10.1007/s00268-019-05119.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: